a leading stem cell firm of Korea, specializes in research and development of therapeutic agents for diseases with damaged cells and incurable diseases and in providing stem cell banking service for future treatment of diseases using adult tissue -derived stem cells.
RBio
has standardized the proprietary technology of stem cell separation and expansion from a small amount of fat tissue and has established the manufacturing process in massive stem cell production.
RBio
will make a great contribution to health and happiness of mankind, and to conquering incurable diseases through research and development of autologous adult-derived stem cells.
Most Commented